Гендерные особенности интервенционного лечения фибрилляции предсердий: проспективное исследование эффективности, безопасности вмешательства и качества жизни пациентов
https://doi.org/10.18705/2311-4495-2016-3-3-34-41
Аннотация
Об авторах
Анна Владимировна ПацюкРоссия
Михаил Леонидович Абрамов
Россия
Дмитрий Сергеевич Лебедев
Россия
Евгений Николаевич Михайлов
Россия
Список литературы
1. Bokeriya l.A., Mahaldiani Z.B., Biniashvili M.B. Modern methods of surgical treatment of atrial fibrillation. Minimally invasive and thoracoscopic surgery. Annaly aritmologii. 2006; 2: 17-27. In russian. [Бокерия Л.А., Махалдиани З.Б., Биниашвили М.Б. Современные методы хирургического лечения фибрилляции предсердий. Миниинвазивные и торакоскопические операции. Анналы аритмологии. 2006; 2: 17-27.]
2. January C.T. Atrial fibrillation management AHA/ACC/HRS guidelines 2014. J Am Coll Cardiol. 2014;64(21): e1-e76.
3. Go A.S., Hylek E.M., Phillips K.A. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18): 2370-2375.
4. Khairy P., Nattel S. New insights into the mechanisms and management of atrial fibrillation. CMAJ. 2002; 167(9): 1012-20.
5. Miyasaka Y., Barnes M.E., Gersh B.J. et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J. 2006; 27(8): 936-941.
6. National guidelines of RCS, RSAS, and CVSS for the diagnosis and treatment of atrial fibrillation. 2012. In Russian. [Национальные рекомендации РКО, ВНОА и АССХ по диагностике и лечению фибрилляции предсердий, 2012]
7. Regitz-Zagrosek V., Oertelt-Prigione S., Prescott E. et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016; 37(1): 24-34.
8. Xiong Q., Proietti M., Senoo K. et al. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences andcardiovascular outcomes. Int J Cardiol. 2015; 191: 172-177.
9. Avgil Tsadok M., Gagnon J., Joza J. et al. Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation. Heart Rhythm. 2015; 12(9): 1979-1986.
10. Chapa D.W., Akintade B., Thomas S.A. et al. Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: A systematic review. Heart Lung. 2015; 44(3): 189-198.
11. Ganesan A.N., Shipp N.J., Brooks A.G., et al. Longterm outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013; 2(2): e004549.
12. Michowitz Y., Rahkovich M., Oral H. et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from aworldwide survey in 34 943 atrial fibrillation ablation procedures. Circulation: Arrhythmia and Electrophysiology. 2014; 7(2): 274-280.
13. Mikhaylov E.N., Orshanskaya V.S., Lebedev A.D., Lebedev D.S., Szili-Torok T. Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: acase-control study. Journal of Cardiovascular Electrophysiology. 2013; 24(8): 888-893.
14. Mikhaylov E.N., Lebedev D.S., Pokushalov E.A. et al. Outcomes of Cryoballoon Ablation in High- and Low-Volume Atrial Fibrillation Ablation Centres: A Russian Pilot-Survey. BioMed Research International. 2015; 2015: 1-8.
15. Arribas F., Ormaetxe J.M., Peinado R., Perulero N., Ramnez P., Badia X. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace. 2010; 12(3): 364-370.
16. Jeong H.K., Cho J.G., Lee K.H., Park H.W., Kim M.R., Lee K.J., Jang S.Y., Park K.H., Sim D.S., Yoon N.S., Yoon H.J., Kim K.H., Hong Y.J., Kim J.H., Ahn Y., Jeong M.H., Park J.C. Determinants of quality of life in patients with atrial fibrillation. Int J Cardiol. 2014; 172(2): e300-2
17. Park H.W., Shen M.J., Lin S.F., Fishbein M.C., Chen L.S., Chen P.S. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol. 2012; 27(1): 24-28.
18. Akutsu Y. Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation. Eur J Nucl Med Mol Imaging. 2010; 37(4): 742-749.
19. Stabile G., De Ruvo E., Grimaldi M., Rovaris G., Soldati E., Anselmino M., Solimene F., Iuliano A., Sciarra L., Schillaci V., Bongiorni M.G., Gaita F., Calô L. Safety and efficacy of pulmonary vein isolation using a circular, open-irrigated mapping and ablation catheter: A multicenter registry. Heart Rhythm. 2015; 12(8): 1782-1788.
20. Efremidis M., Letsas K.P., Lioni L., Giannopoulos G., Korantzopoulos P., Vlachos K., Dimopoulos N.P., Karlis D., Bouras G., Sideris A., Deftereos S. Association of quality of life, anxiety, and depression with left atrial ablation outcomes. Pacing Clin Electrophysiol. 2014; 37(6): 703-711.
21. Sang C.H., Chen K., Pang X.F., Dong J.Z., Du X., Ma H., Liu J.H., Ma C.S., Sun Y.X. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2013; 36(1): 40-45
Рецензия
Для цитирования:
Пацюк А.В., Абрамов М.Л., Лебедев Д.С., Михайлов Е.Н. Гендерные особенности интервенционного лечения фибрилляции предсердий: проспективное исследование эффективности, безопасности вмешательства и качества жизни пациентов. Трансляционная медицина. 2016;3(3):34-41. https://doi.org/10.18705/2311-4495-2016-3-3-34-41
For citation:
Patsyuk A.V., Abramov M.L., Lebedev D.S., Mikhaylov E.N. Gender aspects in catheter ablation of atrial fibrillation: a prospective study of efficacy, safety of the procedure and quality of life of the patients. Translational Medicine. 2016;3(3):34-41. (In Russ.) https://doi.org/10.18705/2311-4495-2016-3-3-34-41